CIK 0001816736 · Large accelerated filer
Disc Medicine, Inc.
Sign in to watch- Ticker
- IRON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 851612845
- Phone
- (617) 674-9274
- Business address
- 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
- Former names
- Gemini Therapeutics, Inc. /DE, FS Development Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $14,489,047
- in 7 filings, $12.6M under 10b5-1 plans
Net −$14,489,047. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-07 | Yu Jonathan Yen-Wen Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −100 | 23,747 | ||
| 2026-06-29 | Khara Rahul Chief Legal Officer | Option exercise 10b5-1 | +1,649 | $14.69 | $24K | 53,822 |
| 2026-06-29 | Khara Rahul Chief Legal Officer | Sale 10b5-1 | −1,649 | $75.00 | $124K | 52,173 |
| 2026-06-29 | Khara Rahul Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,649 | 54,804 | ||
| 2026-06-26 | Khara Rahul Chief Legal Officer | Option exercise 10b5-1 | +851 | $14.69 | $13K | 53,024 |
| 2026-06-26 | Khara Rahul Chief Legal Officer | Sale 10b5-1 | −851 | $75.00 | $64K | 52,173 |
| 2026-06-26 | Khara Rahul Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −851 | 56,453 | ||
| 2026-06-26 | Yu Jonathan Yen-Wen Chief Operating Officer | Option exercise 10b5-1 | +300 | $13.50 | $4K | 54,624 |
| 2026-06-26 | Yu Jonathan Yen-Wen Chief Operating Officer | Sale 10b5-1 | −300 | $72.50 | $22K | 54,324 |
| 2026-06-26 | Yu Jonathan Yen-Wen Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −300 | 23,847 | ||
| 2026-06-22 | Yu Jonathan Yen-Wen Chief Operating Officer | Option exercise 10b5-1 | +9,700 | $13.50 | $131K | 64,024 |
| 2026-06-22 | Yu Jonathan Yen-Wen Chief Operating Officer | Sale 10b5-1 | −9,700 | $72.66 | $705K | 54,324 |
| 2026-06-22 | Yu Jonathan Yen-Wen Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,700 | 24,147 | ||
| 2026-06-18 | Khara Rahul Chief Legal Officer | Option exercise 10b5-1 | +7,500 | $14.69 | $110K | 59,673 |
| 2026-06-18 | Khara Rahul Chief Legal Officer | Sale 10b5-1 | −5,400 | $69.94 | $378K | 54,273 |
| 2026-06-18 | Khara Rahul Chief Legal Officer | Sale 10b5-1 | −1,600 | $70.73 | $113K | 52,673 |
| 2026-06-18 | Khara Rahul Chief Legal Officer | Sale 10b5-1 | −500 | $71.62 | $36K | 52,173 |
| 2026-06-18 | Khara Rahul Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,500 | 57,304 | ||
| 2026-06-18 | Quisel John D Chief Executive Officer | Option exercise 10b5-1 | +34,000 | $9.86 | $335K | 260,064 |
| 2026-06-18 | Quisel John D Chief Executive Officer | Sale 10b5-1 | −22,927 | $69.92 | $1.6M | 237,137 |
Page 4 of 17 · 337 trades